Portola Pharmaceuticals, Inc. announced that Robert Califf, M.D., has retired from Portola's Board of Directors.
Portola Pharmaceuticals, Inc.
Equities
US7370101088
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |